Atea Pharmaceuticals Inc.

2.92
-0.11 (-3.63%)
At close: Mar 03, 2025, 3:59 PM
2.90
-0.68%
After-hours: Mar 03, 2025, 07:14 PM EST

Atea Pharmaceuticals Balance Sheet Statement

Year FY23 FY22 FY21 FY20 FY19 FY18
Cash & Equivalents 143.82M 646.71M 764.38M 850.12M 21.66M 34.49M
Short-Term Investments 434.28M 458.25M n/a n/a n/a n/a
Long-Term Investments n/a 198K 305K 107K 107K 107K
Other Long-Term Assets 1.4M 1.49M 161K n/a 15K n/a
Receivables n/a n/a n/a 5.82M n/a n/a
Inventory n/a n/a n/a n/a n/a n/a
Other Current Assets 12.35M 14.21M 16.06M 15.09M 249K 206K
Total Current Assets 590.46M 660.92M 772.4M 863.48M 21.91M 34.7M
Property-Plant & Equipment 3.12M 4.09M 23K 48K 41K 56K
Goodwill & Intangibles n/a n/a n/a n/a n/a n/a
Total Long-Term Assets 4.51M 5.79M 489K 155K 163K 163K
Total Assets 594.97M 666.71M 772.89M 863.63M 22.07M 34.86M
Account Payables 4.25M 2.55M 4.53M 60K 548K 391K
Deferred Revenue n/a n/a -197K 301.37M 200K 200K
Short-Term Debt 760K 1.44M 197K n/a n/a n/a
Other Current Liabilities 27.36M 14.39M 49.58M 14.37M 1.89M 1.37M
Total Current Liabilities 32.38M 18.48M 56.88M 315.8M 2.44M 1.76M
Long-Term Debt 1.64M 2.4M n/a n/a n/a n/a
Other Long-Term Liabilities 5.76M 5.25M 5.93M 36K 69.21M 69.26M
Total Long-Term Liabilities 7.4M 7.66M 5.93M 36K 69.21M 69.26M
Total Liabilities 39.78M 26.14M 62.81M 315.83M 71.64M 71.02M
Total Debt 2.4M 3.12M 197K n/a n/a n/a
Common Stock 83K 83K 83K 82K 10K 10K
Retained Earnings -195.84M -59.88M 56.03M -65.16M -54.21M -40.18M
Comprehensive Income 207K -684K -0.00 -863.63M -69.11M -69.11M
Shareholders Equity 555.19M 640.57M 710.08M 547.8M -49.57M -36.16M
Total Investments 434.28M 458.25M 305K 107K 107K 107K